Bupivacaine Uses, Dosage, Side Effects and Interactions
Marcaine
Marcaine was approved by the FDA in May 1984 as an injection. An FDA-approved generic with the same active ingredient is listed.
Sensorcaine
Sensorcaine is a bupivacaine brand from before 1982 that comes as an injection. An FDA-approved generic with the same active ingredient is listed.
Xaracoll
Xaracoll was approved by the FDA in August 2020 as an implant. The FDA now lists it as discontinued; generic bupivacaine is still listed.
Posimir
Posimir was approved by the FDA in February 2021 as an injection. The FDA now lists it as discontinued; generic bupivacaine is still listed.
Sensorcaine MPF
Sensorcaine MPF is a brand of bupivacaine that comes as an injection. An FDA-approved generic with the same active ingredient is listed.
Bupivacaine Spinal
Bupivacaine Spinal is a brand name for bupivacaine. Generic bupivacaine is listed with the FDA.
Marcaine Spinal
Marcaine Spinal is a brand of bupivacaine that comes as an injection. An FDA-approved generic with the same active ingredient is listed.
Bupivacaine is a long-acting numbing medicine (local anesthetic) given by injection to block pain during surgery, dental and oral procedures, childbirth, and diagnostic procedures, and to ease pain after surgery.
Quick links
Ask Anything About BupivacaineType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Bupivacaine in Short
- Drug class Amide Local Anesthetic How the FDA classifies it
What it treatsBupivacaine hydrochloride injection is used in adults for local or regional anesthesia or analgesia (numbing and pain relief). Uses include surgery, dental and oral surgery, diagnostic and therapeutic procedures, and obstetrical procedures (childbirth-related). Some products have narrower uses.
- How you get it Prescription only
- Comes asInjection (around a nerve, behind the eye, into the epidural space, into the fluid around the spinal cord, into the lower spine (caudal), into the tissue at the site)Available strengths
- 25 mg/10 mL
- 50 mg/10 mL
- 75 mg/30 mL
- 150 mg/30 mL
- 225 mg/30 mL
- 250 mg/50 mL
See forms and strengths+ 1 more strengthShow fewer strengths
Amount in each mL
- 13.3 mg/mL
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Generic$0.05 to $0.09 per mL
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Bupivacaine (Marcaine, Sensorcaine) is a long-acting local anesthetic, a numbing injection that blocks pain signals along nerves. It is a standard choice for surgery, dental work and childbirth when numbness must last for hours, has been on the U.S. market since about 1972, and FDA-approved generics are listed. Most people tolerate it well, and the side effects people notice are nausea, dizziness or a dip in blood pressure. Its boxed warning reports cardiac arrest, sometimes fatal and very hard to reverse, mostly when the strongest concentration was used for epidurals in childbirth, so that strength is not recommended there.
Key Takeaways From the HelloPharmacist Team
- Speak up right away if you notice tingling around the lips, a metallic taste, ringing ears or sudden restlessness after the injection.
- Before the procedure, tell your team about liver or kidney disease, heart problems, pregnancy, and any past reaction to a numbing injection.
- Expect numbness to last for hours, so protect the numb area from bumps, hot drinks and accidental biting until feeling returns.
- Bring a full medicine list, because MAO inhibitors, tricyclic antidepressants and nonselective beta-blockers can push blood pressure dangerously high with the epinephrine version.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Bupivacaine.
The stronger 0.75% (7.5 mg/mL) concentration is not recommended for epidural anesthesia in childbirth. Cardiac arrest, sometimes fatal and very hard to treat, has been reported in obstetric patients, mostly with this strength. It has followed seizures from the drug reaching the bloodstream by accident. This strength is meant for surgeries needing strong muscle relaxation and long effect.
Patient Information Guide for Bupivacaine
What It’s Used For
Bupivacaine is a local anesthetic used for numbing and pain relief. Uses depend on the product:
- Bupivacaine Hydrochloride injection (including Marcaine): local or regional anesthesia or analgesia in adults for surgery, dental and oral surgery, diagnostic and therapeutic procedures, and obstetrical procedures.
- Bupivacaine Spinal (7.5 mg/mL): spinal anesthesia (subarachnoid block) in adults.
- Exparel: pain relief after surgery by infiltration (ages 6 and older), or by interscalene brachial plexus, popliteal sciatic, or adductor canal nerve block in adults.
- Xaracoll: placed in the surgical site for up to 24 hours of pain relief after open inguinal hernia repair in adults.
How It Works
Bupivacaine blocks the start and travel of nerve impulses, probably by making nerves harder to excite and slowing the signal. Pain signals are stopped first, then temperature, touch, position sense, and muscle tone. Epinephrine, when added, narrows blood vessels so the drug is absorbed more slowly and works longer.
Drug Class
Drug Class
- Amide Local Anesthetic
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Amide Local Anesthetic
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Bupivacaine in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Local Anesthesia
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Amides
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Amides
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Bupivacaine is injected by a trained professional, so there are no missed doses or food rules for you. The dose and strength depend on the procedure, the area numbed, and your health.
The lowest effective dose is used.
- Routes include infiltration, nerve block, epidural, caudal, spinal, and retrobulbar, depending on the product.
- It is not for intrathecal use unless the product is a spinal-specific one.
- Large volumes are not injected quickly. Smaller incremental doses are used when possible.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Bupivacaine Injection
Numbing for surgery and procedures
Adults · Local infiltration Highest dose 400 mg in 24 hours
Step by step
- Up to 70 mL (without epinephrine)
- Up to 175 mg (without epinephrine)
Good to know
Doses may be repeated once every three hours
Adults · 400 mg (1) Highest dose 400 mg in 24 hours
Step by step
- 5-35 mL (without epinephrine)
- 25-175 mg (without epinephrine)
- Moderate to complete motor block
Good to know
Doses may be repeated once every three hours
Adults · 400 mg (2) Highest dose 400 mg in 24 hours
Step by step
- 5-70 mL (without epinephrine)
- 12.5-175 mg (without epinephrine)
- Moderate to complete motor block
Good to know
Doses may be repeated once every three hours
Adults · Retrobulbar Highest dose 400 mg in 24 hours
Step by step
- 2-4 mL
- 15-30 mg
- Complete motor block
Adults · Sympathetic Highest dose 400 mg in 24 hours
Step by step
- 20-50 mL
- 50-125 mg
Adults · 400 mg (3) Highest dose 400 mg in 24 hours
Step by step
- 15-30 mL
- 75-150 mg
- Moderate to complete motor block
Adults · 400 mg (4) Highest dose 400 mg in 24 hours
Step by step
- 15-30 mL
- 37.5-75 mg
- Moderate motor block
Adults · 400 mg (5) Highest dose 400 mg in 24 hours
Step by step
- 10-20 mL
- 75-150 mg
- Complete motor block
Good to know
Not for obstetrical anesthesia
Adults · 400 mg (6) Highest dose 400 mg in 24 hours
Step by step
- 10-20 mL
- 50-100 mg
- Moderate to complete motor block
Adults · 400 mg (7) Highest dose 400 mg in 24 hours
Step by step
- 10-20 mL
- 25-50 mg
- Partial to moderate motor block
Bupivacaine 7.5 mg/mL Injection
Spinal anesthesia for surgery and delivery
Adults · Starting dose Starting dose 6 mg
- Starting dose, 6 mg (0.8 mL)
Adults · Extremity perineal TURP vaginal Usual dose 7.5 mg
- 7.5 mg (1 mL)
Adults · Abdominal abdominal tubal ligation appendectomy Usual dose 12 mg
- 12 mg (1.6 mL)
Adults · Cesarean section Usual dose 7.5 mg to 10.5 mg
- 7.5 mg to 10.5 mg (1 mL to 1.4 mL)
Exparel
Numbing for pain relief after surgery
Adults Highest dose 266 mg
- Up to a maximum dose of 266 mg
Nerve block for pain relief after surgery
Adults · Adductor canal Usual dose 133 mg Highest dose 133 mg
- 133 mg (10 mL) admixed with 50 mg (10 mL) 0.5% bupivacaine HCl, for a total volume of 20 mL
Xaracoll
Numbing for pain relief after surgery
For adults
Usual dose 300 mg once
- 300 mg bupivacaine HCl (three 100 mg implants), each cut in half
- Three halves below mesh site and three halves just below skin closure
Limit Doses above 300 mg not studied
Good to know
Single-dose use
Side Effects
Side effects vary by product and procedure. Reported ones include:
Common side effects
- Nausea
- Vomiting
- Constipation (reported with Exparel)
- Fever (reported with Exparel nerve blocks)
- Headache (reported with Exparel nerve blocks)
- Dizziness
- Low blood pressure
When to get medical help
- Restlessness, anxiety, confusion, or slurred speech after the injection
- Numbness or tingling around the mouth or lips, a metallic taste, ringing in the ears, or blurred vision
- Tremors, twitching, convulsions, or unusual drowsiness
- Slow or shallow breathing, or loss of consciousness
- Bluish or gray skin color, which can signal methemoglobinemia (blood that carries less oxygen)
- Signs of allergic reaction such as breathing trouble or swelling
- Joint pain, stiffness, or loss of motion in the months after joint infusion of a local anesthetic (chondrolysis, or cartilage damage)
Seizures, breathing trouble, heart rhythm changes, allergic reactions, or bluish skin need urgent attention.
Warnings and Precautions
The biggest risk is toxicity from too much drug reaching the bloodstream, which can cause seizures, cardiac arrest, and death. Early signs include restlessness, tingling around the mouth, metallic taste, ringing in the ears, and dizziness.
- The 0.75% concentration is not recommended for obstetrical epidural anesthesia.
- It is contraindicated for intravenous regional anesthesia (Bier block), where cardiac arrest and death were reported.
- Accidental spinal injection can cause a high spinal block with paralysis and breathing failure.
- Methemoglobinemia and chondrolysis (joint cartilage damage after joint infusion) can occur.
- Epinephrine-containing products contain a sulfite that may trigger allergic reactions.
Interactions
These are key interactions to know about:
- Other local anesthetics: toxic effects add up.
- MAO inhibitors and tricyclic antidepressants: severe, prolonged high blood pressure with epinephrine products.
- Ergot-type oxytocics: severe high blood pressure or stroke-type events with epinephrine products.
- Nonselective beta-blockers: high blood pressure and slow heart rate with epinephrine products.
- Nitrates, certain antibiotics, antimalarials, anticonvulsants, and acetaminophen: higher methemoglobinemia risk.
- Potent inhalation anesthetics: serious rhythm problems with epinephrine products.
- Phenothiazines and butyrophenones: may blunt epinephrine's effect.
Interactions Listed in the FDA-Approved Label
From the Bupivacaine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Other local anestheticsWhat happensThe toxic effects of local anesthetics are additive.What to doMonitor for neurologic and cardiovascular effects if coadministration cannot be avoided.
-
Monoamine oxidase inhibitors and tricyclic antidepressantsWhat happensBupivacaine with epinephrine may produce severe, prolonged hypertension.What to doGenerally avoid concurrent use; if necessary, monitor hemodynamic status carefully.
-
Ergot-type oxytocic drugsWhat happensMay cause severe, persistent hypertension or cerebrovascular accidents.What to doAvoid concomitant use.
-
Nonselective beta-adrenergic antagonistsWhat happensMay cause severe hypertension and bradycardia.What to doGenerally avoid; if necessary, monitor blood pressure and heart rate carefully.
-
Drugs associated with methemoglobinemia (nitrates, nitrites, other local anesthetics, antineoplastics, antibiotics, antimalarials, anticonvulsants)What happensIncreased risk of developing methemoglobinemia.
-
Potent inhalation anestheticsWhat happensSerious dose-related cardiac arrhythmias may occur with preparations containing epinephrine.
-
Phenothiazines and butyrophenonesWhat happensMay reduce or reverse the pressor effect of epinephrine.What to doGenerally avoid concurrent use; if necessary, monitor the patient carefully.
Read the label’s full interactions text
7 DRUG INTERACTIONS • Local Anesthetics: The toxic effects of local anesthetics are additive. Monitor for neurologic and cardiovascular effects when additional local anesthetics are administered. • Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: Administration of Bupivacaine Hydrochloride and Epinephrine Injection to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. • Ergot-Type Oxytocic Drugs: Concurrent administration of Bupivacaine Hydrochloride and Epinephrine Injection and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents. • Nonselective Beta-Adrenergic Antagonists: Administration of Bupivacaine Hydrochloride and Epinephrine Injection (containing a vasoconstrictor) in patients receiving nonselective beta-adrenergic antagonists may cause severe hypertension and bradycardia. Concurrent use of these agents should generally be avoided. • Drugs Associated with Methemoglobinemia: Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. • Potent Inhalation Anesthetics: Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administration of potent inhalation anesthetics. 7.1 Local Anesthetics The toxic effects of local anesthetics are additive.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if allergic to bupivacaine or other amide-type local anesthetics.
- Not for obstetrical paracervical block or Bier block.
- Pregnancy: crosses the placenta and may affect the mother, fetus, and newborn.
- Breastfeeding: passes into breast milk, so use only if clearly needed.
- Children: not recommended under 12 for epinephrine-containing products. Exparel infiltration is approved from age 6.
- Older adults: more risk of low blood pressure and may need lower doses.
- Liver or kidney disease: may need dose reduction and closer monitoring.
Overdose
Too much bupivacaine can cause tingling around the mouth, dizziness, confusion, vision changes, and convulsions. Heart effects range from high blood pressure and fast heartbeat to low blood pressure, slow heartbeat, and cardiac arrest. Treatment starts with oxygen and airway support, medicines to stop seizures, and circulatory support. CPR is used if the heart stops.
How Your Body Processes It
How much bupivacaine enters the bloodstream depends on the dose, route, and blood supply at the injection site. After Exparel, bupivacaine was detected in blood for 96 hours after infiltration and up to 168 hours after some nerve blocks. Blood levels with Exparel do not match how well it works locally. Once absorbed, bupivacaine spreads to body tissues. It is broken down by the liver and cleared in part by the kidneys.
Storage
Store bupivacaine liposome injectable suspension vials refrigerated between 2° to 8°C (36° to 46°F). Refrigerate vials. Do not freeze or expose bupivacaine liposome injectable suspension to high temperatures (greater than 40°C or 104°F) for an extended period.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Bupivacaine: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Bupivacaine — the kind of thing our pharmacy team would talk through with you at the counter.
What is bupivacaine used for?
How is bupivacaine given?
What side effects should I expect?
Is bupivacaine safe during pregnancy or childbirth?
Does bupivacaine interact with my other medicines?
Do liver or kidney problems matter?
Is bupivacaine available over the counter?
When was bupivacaine first available?
Who makes bupivacaine?
What is the brand name of bupivacaine?
What is the generic name of Marcaine?
What drug class is bupivacaine?
Is there a generic version of bupivacaine?
What strengths does bupivacaine come in?
How much does bupivacaine cost?
Is there a bupivacaine shortage?
Where can I read the bupivacaine prescribing information (package insert)?
Is bupivacaine gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Bupivacaine
Skip the scrolling. Ask in your own words and get an answer from Bupivacaine’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Bupivacaine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Bupivacaine on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Bupivacaine Forms and Strengths (How It Comes)
Bupivacaine comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Bupivacaine inactive ingredients by manufacturer.
Injection
How this form is used
- Marcaine and Bupivacaine Hydrochloride injection are used in adults for local or regional anesthesia or analgesia for surgery, dental and oral surgery, diagnostic and therapeutic procedures, and obstetrical procedures.
- Exparel is used for pain relief after surgery by infiltration (ages 6 and older) or by certain nerve blocks in adults.
- Bupivacaine Hydrochloride injection is not for intrathecal use.
- Bupivacaine Hydrochloride multiple-dose vials with preservatives should be avoided for epidural or caudal anesthesia.
- Bupivacaine Hydrochloride single-dose vial leftovers without preservatives are discarded after first use.
Show 4 more strengths Show fewer strengths
Bupivacaine on the U.S. Market: Products, Makers and Brands
How Bupivacaine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
24 companies list 104 Bupivacaine product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1972. Brand names in the directory today include Marcaine, Sensorcaine, Sensorcaine MPF and 2 more; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (26) · Unfinished injection, solution (1) · Unfinished injection, suspension, liposomal (1) · Unfinished liquid (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Bupivacaine Is Used (Medicaid Data)
How many Bupivacaine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Bupivacaine prescribed? Of the 1,682 medications we measure, Bupivacaine ranks #424 by Medicaid prescriptions — more than 75% of them.
Utilization by Bupivacaine product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
10 ML bupivacaine hydrochloride 2.5 MG/ML Injection Most dispensed
6 of 37 listed NDCs had Medicaid claims. RxNorm 1725078
30 ML bupivacaine hydrochloride 2.5 MG/ML Injection
9 of 28 listed NDCs had Medicaid claims. RxNorm 1725082
30 ML bupivacaine hydrochloride 5 MG/ML Injection
8 of 28 listed NDCs had Medicaid claims. RxNorm 1724884
10 ML bupivacaine hydrochloride 5 MG/ML Injection
7 of 40 listed NDCs had Medicaid claims. RxNorm 1724880
bupivacaine hydrochloride 5 MG/ML Injectable Solution
10 of 45 listed NDCs had Medicaid claims. RxNorm 1012404
bupivacaine hydrochloride 2.5 MG/ML Injectable Solution
7 of 34 listed NDCs had Medicaid claims. RxNorm 1012396
20 ML bupivacaine liposome 13.3 MG/ML Injection
2 of 4 listed NDCs had Medicaid claims. RxNorm 1191508
10 ML bupivacaine liposome 13.3 MG/ML Injection
2 of 4 listed NDCs had Medicaid claims. RxNorm 1745061
10 ML bupivacaine hydrochloride 7.5 MG/ML Injection
6 of 19 listed NDCs had Medicaid claims. RxNorm 1724787
2 ML bupivacaine hydrochloride 7.5 MG/ML Injection
2 of 16 listed NDCs had Medicaid claims. RxNorm 1724784
30 ML bupivacaine hydrochloride 7.5 MG/ML Injection
3 of 23 listed NDCs had Medicaid claims. RxNorm 1724786
Other Bupivacaine products: packs and listings not matched to one strength and form
19 of 99 listed NDCs had Medicaid claims.
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 81 of the 377 listed Bupivacaine NDCs had Medicaid claims.
Compare Bupivacaine Products
A representative set of FDA-listed product records for Bupivacaine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 5 mg/mL | Perineural | A-S Medication Solutions | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Anthea Pharma Private Limited | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Anthea Pharma Private Limited | ANDA | View NDC → |
| 5 mg/mL | Perineural | Anthea Pharma Private Limited | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Anthea Pharma Private Limited | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | Anthea Pharma Private Limited | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Asclemed USA, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal | Asclemed USA, Inc. | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal | Asclemed USA, Inc. | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration | Asclemed USA, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 7.5 mg/mL | Subarachnoid | Brookfield Pharmaceuticals, LLC. | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Cardinal Health 107, LLC | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Eugia US LLC | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Perineural | Eugia US LLC | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration | Fosun Pharma USA Inc. | ANDA | View NDC → |
| 5 mg/mL | Epidural | Fosun Pharma USA Inc. | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 5 mg/mL | Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Henry Schein, Inc | ANDA | View NDC → |
| 5 mg/mL | Perineural | Henry Schein, Inc | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Henry Schein, Inc. | NDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Henry Schein, Inc. | NDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Henry Schein, Inc. | NDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Henry Schein, Inc. | ANDA | View NDC → |
| 5 mg/mL | Perineural | Henry Schein, Inc. | NDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | NDA | View NDC → |
| 5 mg/mL | Perineural | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| 5 mg/mL | Perineural | HF Acquisition Co LLC, DBA HealthFirst | NDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Perineural | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Hospira, Inc. | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Hospira, Inc. | ANDA | View NDC → |
| 5 mg/mL | Perineural | Hospira, Inc. | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | Hospira, Inc. | ANDA | View NDC → |
| 7.5 mg/mL | Subarachnoid | Hospira, Inc. | NDA | View NDC → |
| 7.5 mg/mL | Subarachnoid | Hospira, Inc. | ANDA | View NDC → |
| 25 mg/10 mL | Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | NDA | View NDC → |
| 50 mg/10 mL | Epidural, Intracaudal, Perineural | Hospira, Inc. | NDA | View NDC → |
| 75 mg/30 mL | Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | NDA | View NDC → |
| 150 mg/30 mL | Epidural, Intracaudal, Perineural | Hospira, Inc. | NDA | View NDC → |
| 225 mg/30 mL | Epidural, Retrobulbar | Hospira, Inc. | NDA | View NDC → |
| 250 mg/50 mL | Perineural | Hospira, Inc. | NDA | View NDC → |
| 7.5 mg/mL | Subarachnoid | Huons Co., Ltd. | ANDA | View NDC → |
| 13.3 mg/mL | Infiltration | Jiangsu Hengrui Pharmaceuticals Co., Ltd. × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Medical Purchasing Solutions, LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Perineural | Medical Purchasing Solutions, LLC | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Meitheal Pharmaceuticals Inc | ANDA | View NDC → |
| 5 mg/mL | Perineural | Meitheal Pharmaceuticals Inc | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration | Onesource Specialty Pharma Limited × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration | Onesource Specialty Pharma Limited | ANDA | View NDC → |
| 5 mg/mL | Epidural | Onesource Specialty Pharma Limited × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Infiltration | Onesource Specialty Pharma Limited | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Retrobulbar | Onesource Specialty Pharma Limited × 2 listings | ANDA | View NDC → |
| 13.3 mg/mL | Infiltration | Pacira Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | ProPharma Distribution | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | ProPharma Distribution | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 5 mg/mL | Infiltration, Perineural | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Sportpharm LLC | ANDA | View NDC → |
| 2.5 mg/mL | Infiltration, Perineural | Sportpharm LLC | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Sportpharm LLC | ANDA | View NDC → |
| 2.5 mg/mL | Epidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC × 2 listings | ANDA | View NDC → |
| 2.5 mg/mL | Perineural | Xellia Pharmaceuticals USA LLC | ANDA | View NDC → |
| 5 mg/mL | Epidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Perineural | Xellia Pharmaceuticals USA LLC | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC × 2 listings | ANDA | View NDC → |
Showing 104 of 104 products — FDA National Drug Code Directory. See every product, package size and price: browse all 104 Bupivacaine NDCs →
Bupivacaine Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Bupivacaine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Bupivacaine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Bupivacaine FDA Approval History
How Bupivacaine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Bupivacaine Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 2 Bupivacaine recalls since July 2021, covering 3 product listings. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only, Manufactured by: Houns Co., Ltd, 100, Bio valley, Je-cheor-Si, Chungcheongbuk-dc, Korea, ND… Lots: All lots within expiry FDA record D-0530-2026 →
- Bupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1095-2022 →
- Bupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-169-10 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-0998-2022 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Bupivacaine in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 3
- Strengths
- 17
- Forms in current FDA listings
- 2 of 3
RxCUI 1815 -
Dose form (SCDF) Drug ImplantNo current FDA listing
RxCUI 2395790Its strength (SCD)-
100 mg
hydrochloride
RxCUI 2395791
-
100 mg
hydrochloride
-
Dose form (SCDF) InjectionIn current FDA listings
RxCUI 1724783Its 13 strengths (SCD)-
2 mL bupivacaine hydrochloride 7.5 mg/mL
RxCUI 1724784 -
5 mL bupivacaine 132 mg/mL
RxCUI 2563412 -
5 mL bupivacaine hydrochloride 2.5 mg/mL
RxCUI 2178759 -
5 mL bupivacaine hydrochloride 5 mg/mL
RxCUI 2178760 -
10 mL bupivacaine hydrochloride 2.5 mg/mL
RxCUI 1725078 -
10 mL bupivacaine hydrochloride 5 mg/mL
RxCUI 1724880 -
10 mL bupivacaine hydrochloride 7.5 mg/mL
RxCUI 1724787 -
10 mL bupivacaine liposome 13.3 mg/mL
RxCUI 1745061 -
20 mL bupivacaine hydrochloride 2.5 mg/mL
RxCUI 1725696 -
20 mL bupivacaine liposome 13.3 mg/mL
RxCUI 1191508 -
30 mL bupivacaine hydrochloride 2.5 mg/mL
RxCUI 1725082 -
30 mL bupivacaine hydrochloride 5 mg/mL
RxCUI 1724884 -
30 mL bupivacaine hydrochloride 7.5 mg/mL
RxCUI 1724786
-
2 mL bupivacaine hydrochloride 7.5 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Bupivacaine Supply and Shortage Status
Whether Bupivacaine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Bupivacaine Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Bupivacaine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2024.
For the generic 5 mg/mL injection, pharmacies paid an average of $0.086 per mL as of Nov 18, 2026, up 4.9% from $0.082 a year earlier.
- What pharmacies pay now
- $0.086
- per mL, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $0.086 on Oct 21, 2026
- Last 12 months
- Up 4.9%
- from $0.082 on Nov 19, 2025
- Lowest and highest since Nov 2024
- $0.070 to $0.086
- per mL
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.086 |
| Oct 2026 | $0.086 |
| Sep 2026 | $0.086 |
| Aug 2026 | $0.086 |
| Jul 2026 | $0.086 |
| Jun 2026 | $0.086 |
| May 2026 | $0.086 |
| Apr 2026 | $0.086 |
| Mar 2026 | $0.083 |
| Feb 2026 | $0.083 |
| Jan 2026 | $0.082 |
| Dec 2025 | $0.078 |
| Nov 2025 | $0.082 |
| Oct 2025 | $0.081 |
| Sep 2025 | $0.083 |
| Aug 2025 | $0.078 |
| Jul 2025 | $0.075 |
| Jun 2025 | $0.077 |
| May 2025 | $0.072 |
| Apr 2025 | $0.070 |
| Mar 2025 | $0.070 |
| Feb 2025 | $0.073 |
| Jan 2025 | $0.076 |
| Dec 2024 | $0.073 |
| Nov 2024 | $0.073 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Injection · Perineural | 2.5 mg/mL | Generic | $0.048 per mL | NDC details & price history |
| Injection · Infiltration, Perineural | 5 mg/mL | Generic | $0.086 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Bupivacaine Brand Names
Bupivacaine has 7 brand names on record: Marcaine, Sensorcaine, Xaracoll, Posimir and others. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Bupivacaine: Manufacturers and Labelers
24 companies list Bupivacaine products with the FDA. By number of product records, the largest are Hospira, Inc., Eugia US LLC, Hikma Pharmaceuticals USA Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Bupivacaine Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Pacira Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →